HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GEA 3175

Also Known As:

GEA-3175

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Triazoles: 1533
      - GEA 3175: 3

Experts

1.	Simonsen, Ulf: 2 articles (11/2006 - 05/2005)
2.	Laursen, Britt Elmedal: 1 article (11/2006)
3.	Mulvany, Michael: 1 article (11/2006)
4.	Pilegaard, Hans: 1 article (11/2006)
5.	Stankevicius, Edgaras: 1 article (11/2006)
6.	Elmedal, Britt: 1 article (05/2005)
7.	Mulvany, Michael J: 1 article (05/2005)

Related Diseases

1.	Pulmonary Hypertension 11/01/2006 - "Clearly, further in vivo studies involving animal models are required to clarify safety issues and whether GEA 3175 can be used in the treatment of pulmonary hypertension and/or airway diseases." 05/23/2005 - "The dilatation of both pulmonary small arteries and airways by GEA 3175 seems advantageous, if it is considered administered as inhalation therapy for pulmonary hypertension."
2.	Uremia 09/01/1998 - "Adenosine 5'-diphosphate-induced platelet aggregation in uremia shows resistance to inhibition by the novel nitric oxide donor GEA 3175 but not by S-nitroso-N-acetylpenicillamine."

Related Drugs and Biologics

1.	S-Nitroso-N-Acetylpenicillamine
2.	Nitric Oxide Donors
3.	Adenosine (Adenocard)

Related Therapies and Procedures

1.	Respiratory Therapy (Therapy, Respiratory)